Hangzhou Tigermed
A contract research company providing whole process clinical trial services for the R&D of pharmaceuticals.
Launch date
Employees
Market cap
$5.4b
Enterprise valuation
$5.5b (Public information from Sep 2024)
Share price
CNY49.73 300347.SZ
小营街道 Zhejiang (HQ)
Authorizing premium user...